Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024 2025
Months
January February March April July May June August September October November December
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

Student one of ten Google Young Minds
2012-04-23

 

Sibusiso Tshabalala is making strides as an international young leader.
23 April 2012

Third-year B.Com Law student, Sibusiso Tshabalala from our university, is one of ten of Google’s Young Minds for 2012. He made it to the top thirty from a pool of 1 700 applicants at the beginning of April 2012.

“The standard of other competitors and the panel of judges were extremely high. I was excited to receive the news that I had made it,” he says.

Annually, Google searches for ten students internationally who demonstrate strong leadership capabilities. This once-in-a-lifetime opportunity is given to students who also have an entrepreneurial drive and a commitment to social activism. Sibusiso was selected for his involvement in renovating libraries and training budding public speakers. His projects also involve encouraging literacy and critical thinking in poor areas in the Free State by establishing reading clubs.

Sibusiso will be attending the Google Zeitgeist in London from 20 to 22 May 2012.

At the conference, he will have the opportunity to meet some of the world’s greatest minds. Over 400 influential business leaders and visionaries from around the world will be hosted. Speakers include Prof. Stephen Hawking, former Lucasian Professor of Mathematics: University of Cambridge; Sir Richard Branson, Virgin Group; Eric Schmidt, Chairman: Google; Larry Page, CEO: Google; Angela Ahrendts, CEO: Burberry, and international musician will.i.am.

The ten winners will also take part in a series of ‘master classes’ with the aim of mentoring them to help further their future projects.

His achievements include the 2010 winner of the National SAGE Competition (Students for the Advancement of Global Entrepreneurship). He represented South Africa in Brazil that same year and was also National Winner of the Best Speaker Award at the 2011 South African National Universities Debating Championships. He was ranked as one of the top ten debaters in Africa at the Pan African Universities Debating Championships held in Bulawayo, Zimbabwe in 2011. Sibusiso recently chaired the committee that organised the first university based CANSA Relay for Life Event in South Africa. This took place at the UFS in February 2012.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept